Articles
Featured Articles
Read our latest stories on the people and scientific innovations making a difference in patients’ lives.
How Pfizer is fostering meaningful growth for every colleague, everywhere
Redefining Career Growth at PfizerAt Pfizer, we’re transforming and redefining ‘growth’ for our colleagues. To live and deliver on our purpose: breakthroughs that change patients’ lives, we need to continually grow ourselves and those around us. Doing this – while thinking big and pursuing bold goals – will help us to bring medicines and vaccines forward that can radically alter the course of a disease. We now see growth as a part of our DNA: We grow every day. In practice, this means promoting...
Insurers and middlemen profiting more from prescription drugs
Vaccines continue to help keep millions safe despite an ever-changing adversary, and there is new hope in the form of treatments that may prevent the most severe outcomes when infections do occur. While science drives us forward, we are also focused on the common goal of finding ways to lower healthcare costs for patients.As we all look for policies to achieve that goal, it’s imperative to look at all the cost drivers in the prescription drug system, and new data demonstrates for the first time...
Reasons to Reject the Dangerous Medicare Pricing Proposal
Making sure that medicines are accessible and affordable for patients is a goal we all share. But policymakers are considering a dangerous Medicare reform policy that could threaten the future of groundbreaking cures.The policy would allow government “negotiations” on the price of medicines for Medicare, and would give government a greater hand in dictating prices, rather than the current system that promotes competition. Moreover, this misguided policy would repeal a key provision of the...
One Year Later: Pfizer Update on Progress of Humanitarian Assistance Program
In November 2016, Pfizer Inc. announced a major expansion of its humanitarian assistance program enabling broader access to its pneumococcal conjugate vaccine (PCV) in humanitarian emergency settings. During the year since, the Company has made important progress on a number of fronts to support access. In January 2017, our multi dose vial (MDV) of PCV became available in the world's poorest countries through our partnership with Gavi, the Vaccine Alliance. It has also been used to vaccinate...
Supporting Refugee Communities In Africa
Photo Credit: International Rescue CommitteeToday the Pfizer Foundation* is pleased to announce new funding for three important humanitarian organizations to specifically support their work with refugees and internally displaced people. The grant recipients include the International Medical Corps., the International Rescue Committee (IRC), and World Vision. The grants will support activities in acute refugee settings in areas that have some of the greatest need."The ongoing refugee crisis is one...
Meet The People Of PGS: Vanessa
Through the “People of PGS” series, we continue to spotlight the names and faces behind the great work we do in PGS. Next up is Vanessa, Site Leader at Meridian in St. Louis, who also has competed on Team USA’s Dragon Boat Racing team!While Vanessa started her career designing high-speed manufacturing and packing machinery for another industry, today she is proud to say that her role at Pfizer and her time in the pharma industry give her the opportunity to help patients.Vanessa’s 22-year pharma...
Inroads X Pfizer – A Progressive Partnership
Innovation isn’t easy. Otherwise everyone could do it.It takes many talented people putting their heads together to find inventive ways around some of the world’s biggest and toughest challenges. But, on top of being talented, everyone needs to be talented in different ways.If you send a group of people with similar backgrounds and experiences a challenge, chances are they’d approach it in the same way. But that is not how innovation happens. You need different people. From different backgrounds...
Meet the People of PGS: Daniela
Through the “People of PGS” series, we spotlight the names and faces behind the great work we do in PGS. Next up is Daniela, a PGS colleague who recently completed a one-year assignment as part of the CEO Action for Racial Equity Fellowship Program. Most people would consider Daniela an expert in Supply Chain, thanks to her 16-year career working across the pharmaceutical industry, including five years at Pfizer. But when a unique career opportunity presented itself, Daniela had the courage to...
The science behind hiring and interviewing
We’re not the first business to discover how technology increases diversity, but we’ve been among the first to adopt it and make it work.Here’s the background. HireVue is an AI-driven platform which helps us consider more applicants, drive consistency, reduce any unconscious bias and make better decisions. From diversifying our talent pool to making interviews structured, it ensures we won’t rely on assumptions and could increase our diversity by up to 16%. Just this week, all of our early...
Meet The People Of PGS: Connor
Through the “People of PGS” series, we spotlight the names and faces behind the great work we do in PGS. Next up is Connor, a Senior Environmental Health & Safety (EHS) Associate, who turned his passion for nature into a rewarding career. For Connor, no two days are exactly the same – and that’s just how he likes it. At the start of the week, he could be reviewing storm water mitigation practices at a construction site, and at the end of the week, he could be in a manufacturing clean room...
Meet The People Of PGS: John
Through the “People of PGS” series, we continue to spotlight the names and faces behind the great work we do in PGS. Next up is John, a Digital Business Analyst in Ireland who served as an official at the Tokyo Olympics this summer. As a Digital Business Analyst, John ensures the Pfizer Digital systems at a Pfizer facility in Ireland run smoothly. He works with stakeholders from across the site to understand their business requirements and collaborates with Pfizer Digital to identify solutions...
Net Zero by 2040: How Pfizer is Fighting Climate Change with Ambitious Science Based Goals
In 2015, on the eve of the Paris Agreement, Pfizer was one of the first companies in the world to seek and gain approval of its greenhouse gas emission reduction goal from the Science Based Targets Initiative (SBTi). Since then, leading scientific researchers, together with coalitions such as SBTi, have urged the private and public sectors to increase their commitments to address the growing urgency of the climate crisis. The science is irrefutable; action is required to meet the goals of the Pa...
Media Resources & Contact Information
Anyone may view our press releases, press statements, and press kits. However, to ensure that customers, investors, and others receive the appropriate attention, Pfizer Media Contacts may only respond to calls and emails from professional journalists.